J Gastroenterol Hepatol Endosc | Volume 7, Issue 1 | Research Article | Open Access

Six Months of Thiazolidine Carboxylic Acid Treatment Causes Significant Improvement in FibroTest in Patients with Non-Alcoholic Fatty Liver Disease

Partyka M1, Piotrowski D2*, Partyka P3, Rzucidło M3, Kluz M3, Błotnicki M3, Jaroszewicz J2, Gutkowska D1 and Gutkowski K1

1Institute of Medical Sciences, Medical College of Rzeszow, University of Rzeszow, Poland
2Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Poland
3Department of Gastroenterology and Hepatology with General Medicine Unit, University of Rzeszow, Poland

^*Correspondance to: Damian Piotrowski 

Fulltext PDF

Abstract

Partyka M, Piotrowski D, Partyka P, Rzucidło M, Kluz M, Błotnicki M, et al. Six Months of Thiazolidine Carboxylic Acid Treatment Causes Significant Improvement in FibroTest in Patients with Non-Alcoholic Fatty Liver Disease. J Gastroenterol Hepatol Endosc. 2022; 7(1): 1110.

Keywords:

Thioproline; Liver fibrosis; FibroTest

Citation:

.